Loading…
Based on limited metadata, AniCell Biotech received an FDA Warning Letter on July 3, 2018, regarding animal and veterinary products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's regulatory authority over animal and veterinary products, though the specific issuing office is not identified in the metadata provided. To understand the exact compliance issues cited, the complete Warning Letter text would be required.